Comparison of humoral immune responses elicited by DNA and protein vaccines based on merozoite surface protein-1 from Plasmodium yoelii, a rodent malaria parasite

Journal of Immunology

Volumn 161, Issue 8, 1998, Pages 4211-4219

  Kang, Yang ^a   Calvo, Paul A ^a,b   Daly, Thomas M ^a   Long, Carole A ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; MALARIA VACCINE; PROTOZOAL PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HUMORAL IMMUNITY; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; MALARIA; MALARIA CONTROL; MALE; MEROZOITE; MOUSE; NONHUMAN; PLASMODIUM YOELII; PRIORITY JOURNAL; VACCINATION;

ANIMALS; ANTIBODY FORMATION; DNA, PROTOZOAN; MALARIA; MALARIA VACCINES; MEROZOITE SURFACE PROTEIN 1; MICE; PLASMODIUM YOELII; VACCINES, DNA;

EID: 0032532278     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Taubes, G. 1997. Salvation in a snippet of DNA? Science 278:1713.
2. Donnelly, J. J., J. B. Ulmer, J. W. Shiver, and M. A. Liu. 1997. DNA vaccines. Annu. Rev. Immunol. 15:617.
3. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Felgner, V. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. de Witt, A. A. Friedman, L. A. Hawe, K. R. Leander, D. Martinez, H. C. Perry, J. W. Shiver, D. L. Montgomery, and M. A. Liu. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745.
4. Donnelly, J. J., A. Friedman, D. Martinez, D. L. Montgomery, J. W. Shiver, S. L. Motzel, J. B. Ulmer, and M. A. Liu. 1995. Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nat. Med. 1:583.
5. Robinson, H. L., L. A. Hunt, and R. G. Webster. 1993. Protection against a lethal influenza virus challenge by immunization with a hemagglutinin-expressing plasmid DNA. Vaccine 11:957.
6. Cox, G. J., T. J. Zamb, and L. A. Babiuk. 1993. Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J. Virol. 67:5664.
7. Xiang, Z. Q., S. Spitalnik, M. Tran, W. H. Wunner, J. Cheng, and H. C. Ertl. 1994. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199:132.
8. Sedegah, M., R. Hedstrom, P. Hobart, and S. L. Hoffman. 1994. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA 91:9866.
9. Gurunathan, S., D. L. Sacks, D. R. Brown, S. L. Reiner, H. Charest, N. Glaichenhaus, and R. A. Seder. 1997. Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. J. Exp. Med. 186:1137.
10. Wang, B., J. Boyer, V. Srikantan, L. Coney, R. Carrano, C. Phan, M. Merva, K. Dang, M. Agadjanan, L. Gilbert, K. E. Ugen, W. E. Williams, and D. B. Weiner. 1993. DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates. DNA Cell Biol. 12:799.
11. Ulmer, J. B., R. R. Deck, C. M. De Witt, A. Friedman, J. J. Donnelly, and M. A. Liu. 1994. Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine 12:1541.
12. Davis, H.L., M. L. Michel, AND R. G. Whalen. 1993. DNA-based immunization for hepatitis B induces continuous secretion of antigen and high levels of circulating antibody. Hum. Mol. Genet. 2:1847.
13. Wang, B., J. Boyer, V. Srikantan, K. Ugen, L. Gilbert, C. Phan, K. Dang, M. Merva, M. G. Agadjanyan, M. Newman, R. Carrano, D. McCallus, L. Coney, W. V. Williams, and D. B. Weiner. 1995. Induction of humoral and cellular immune responses to the human immunodeficiency type 1 virus in nonhuman primates by in vivo DNA inoculation. Virology 211:102.
14. Lu, S., J. C. Santoro, D. H. Fuller, J. R. Haynes, and H. L. Robinson. 1995. Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice. Virology 209:147.
15. + T lymphocytes. J. Immunol. 155:259.
16. McClements, W.L., M. E. Armstrong, R. D. Keys, and M. A. Liu. 1996. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc. Natl. Acad. Sci. USA 93:11414.
17. Bourne, N., L. R. Stanberry, D. I. Bernstein, and D. Lew. 1996. DNA immunization against experimental genital herpes simplex virus infection. J. Infect. Dis. 173:800.
18. Justewicz, D. M., M. J. Morin, H. L. Robinson, and R. G. Webster. 1995. Antibody-forming cell response to virus challenge in mice immunized with DNA encoding the influenza virus hemagglutinin. J. Virol. 69:7712.
19. Deck, R. R, C. M. DeWitt, J. J. Donnelly, M. A. Liu, and J. B. Ulmer. 1997. Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine. Vaccine 15:71.
20. Olliaro, P., J. Cattani, and Dyann F. Wirth. 1996. Malaria: the submerged disease. JAMA 275:230.
21. Long, C. A. 1993. Immunity to blood stages of malaria. Curr. Opin. Immunol. 5:548.
22. Nussenzweig, R. S., and C. A. Long. 1994. Malaria vaccines: multiple targets. Science 265:1381.
23. Doolan, D. L., R. C. Hedstrom, R. Wang, M. Sedegah, L. F. Scheller, P. Hobart, J. A. Norman, and S. L. Hoffman. 1997. DNA vaccines for malaria: the past, the present, and the future. Indian J. Med. Res. 106:109.
24. Doolan, D. L., and S. L. Hoffman. 1997. Multigene vaccination against malaria: a multistage, multiimmune response approach. Parasitol. Today. 13:171.
25. Gardner, M. J., D. L. Doolan, R. C. Hedstrom, R. Wang, M. Sedegah, R. A. Gramzinski, J. C. Aguiar, H. Wang, M. Margalith, P. Hobart, and S. L. Hoffman. 1996. DNA vaccines against malaria: immunogenicity and protection in a rodent model. J. Pharmacol. Sci. 85:1294.
26. + cell-, interferon γ-, and nitric oxide-dependent immunity. J. Exp. Med. 183:1739.
27. Cooper, J. 1993. Merozoite surface antigen of Plasmodium. Parasitol. Today 9:50.
28. Holder, A. A., and R. R. Freeman. 1981. Immunization against blood-stage rodent malaria using purified parasite antigens. Nature 294:361.
29. Siddiqui, W. A., L. Q. Tam, K. J. Kramer, G. S. Hui, K. M. Yamaga, S. P. Chang, E. B. Chan, and S. C. Kan. 1987. Merozoite surface coat precursor completely protects Aotus monkeys against Plasmodium falciparum malaria. Proc. Natl. Acad. Sci. USA 84:3014.
30. Etlinger, H. M., P. Caspers, H. Matile, H.-J. Schoenfeld, D. Stueber, and B. Takacs. 1991. Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum. Infect. Immun. 59: 3498.
31. Tian, J. H., S. Kumar, D. C. Kaslow, and L. H. Miller. 1997. Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii. Infect. Immun. 65: 3032.
32. Daly, T. M., J. M. Burns, Jr., and C. A. Long. 1992. Comparison of the C-terminal, cysteine-rich domain of the merozoite surface protein-1 from several strains of Plasmodium yoelii. Mol. Biochem. Parasitol. 52:279.
33. Tanabe, K., M. Mackay, M. Goman, and J. Scaife. 1987. Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum. J. Med. Biol. 195:273.
34. Miller, L. H., T. Roberts, M. Shahabuddin, and T. F. McCutchan. 1993. Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). Mol. Biochem. Parasitol. 59:1.
35. Kang, Y., and C. A. Long. 1995. Sequence heterogeneity of the C-terminal, Cys-rich region of the merozoite surface protein-1 (MSP-1) in field samples of Plasmodium falciparum. Mol. Biochem. Parasitol. 73:103.
36. Blackman, M. J., I. T. Ling, S. C. Nicholls, and A. A. Holder. 1991. Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. Mol. Biochem. Parasitol. 49:29.
37. Majarian, W. R., T. M. Daly, W. P. Weidanz, and C. A. Long. 1984. Passive protection against murine malaria with an IgG3 monoclonal antibody. J. Immunol. 132:3131.
38. Daly, T. M., and C. A. Long. 1993. A recombinant 15-kilodalton carboxyl terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein-1 induces a protective response in mice. Infect. Immun. 61:2462.
39. Daly, T. M., and C. A. Long. 1995. Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria. J. Immunol. 155:236.
40. Ling, I. T., S. A. Ogun, and A. A. Holder. 1994. Immunization against malaria with a recombinant protein. Parasite Immunol. 16:63.
41. Tian, J. H., L. H. Miller, D. C. Kaslow, J. Ahlers, M. F. Good, D. W. Alling, J. A. Berzofsky, and S. Kumar. 1996. Genetic regulation of protective immune response in congenic strains of mice vaccinated with a subunit malaria vaccine. J. Immunol. 157:1176.
42. Kumar, S., A. Yadava, D. B. Keister, J. H. Tian, M. Ohl, K. A. Perdue-Greenfield, L. H. Miller, and D. C. Kaslow. 1995. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys. Mol. Med. 1:325.
43. Chang, S. P., S. E. Case, W. L. Gosnell, A. Hashimoto, K. J. Kramer, L. Q. Tam, C. Q. Hashiro, C. M. Nikaido, H. L. Gibson, C. T. Lee-Ng, P. J., Barr, B. T. Yokota, and G. S. Hui. 1996. A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria. Infect. Immun. 64:253.
44. Chen, M., M. P. Marinkovich, A. Veis, X. Cai, C. N. Rao, E. A. O'Toole, and D. T. Woodley. 1997. Interaction of the amino-terminal noncollagenous (NC1) domain of the VII collagen with extracellular matrix components: a potential role in epidermal-dermal adherence in human skin. J. Biol. Chem. 272:14516.
45. Calvo, P. A., T. M. Daly, and C. A. Long. 1996. Plasmodium yoelii: the role of the individual epidermal growth factor-like domains of the merozoite surface protein-1 in protection from malaria. Exp. Parasitol. 82:54.
46. Daly, T. M., and C. A. Long. 1996. Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection. Infect. Immun. 64: 2602.
47. Pullen, G. R., M. G. Fitzgerald, and C. S. Hosking. 1986. Antibody avidity determination by ELISA using thiocyanate elution. J. Immunol. Methods 86:83.
48. Ling, I. T., S. A. Ogun, and A. A. Holder. 1995. The combined epidermal growth factor-like modules of Plasmodium yoelii merozoite surface protein-1 are required for a protective immune responses to the parasite. Parasite Immunol. 17:425.
49. Dieckmann-Schuppert, A., S. Bender, M. Odenthal-Schnittler, E. Bause, and R. T. Schwarz. 1992. Apparent lack of N-glycosylation in the asexual intraerythrocytic stage of Plasmodium falciparum. Eur. J. Biochem. 205:815.
50. Bottiger, B., and I. P. Jensen. 1997. Maturation of rubella IgG avidity over time after acute rubella infection. Clin. Diagn. Virol. 8:105.
51. Grangeot-Keros, L., M. J. Mayaux, P. Lebon, F. Freymuth, G. Eugene, R. Stricker, and E. Dussaix. 1997. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J. Infect. Dis. 175:944.
52. Jenum, P. A., B. Stray-Pedersen, and A. G. Gundersen. 1997. Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. J. Clin. Microbiol. 35:1972.
53. Zinkernagel, R. M. 1997. Protective antibody responses against viruses. J. Biol. Chem. 378:725.
54. Brunell, P. A., V. Vimal, M. Sandu, T. M. Courville, E. Daar, and V. Isreale. 1995. Abnormalities of measles antibody response in human immunodeficiency virus type 1 (HIV-1) infection. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 10:540.
55. Wabl, M., and C. Steinberg. 1996. Affinity maturation and class switching. Curr. Opin. Immunol. 8:89.
56. Robinson, H. L., and C. A. T. Torres. 1997. DNA vaccines. Semin. Immunol. 9:271.
57. Leitner, W. W., M. C. Seguin, W. R. Ballou, J. P. Seitz, A. M. Shultz, M. J. Sheehy, and J. A. Lyon. 1997. Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites. J. Immunol. 159:6112.
58. Soothill, J. F., and M. W. Steward. 1971. The immunopathological significance of the heterogeneity of antibody affinity. Clin. Exp. Immunol. 9:193.
59. Ling, I. T., S. A. Ogun, P. Momin, R. L. Richards, N. Garcon, J. Cohen, W. R. Ballou, and A. A. Holder. 1997. Immunization against the murine malaria parasite Plasmodium yoelii using a recombinant protein with adjuvants developed for clinical use. Vaccine 15:1562.